Profile | GDS2987 / GI_29029554-I |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 17.6 | 51 |
GSM215244 | HMVEC_vehicle_rep2 | 18.4 | 43 |
GSM215253 | HMVEC_vehicle_rep3 | 12.4 | 39 |
GSM215254 | HMVEC_atorvastatin_rep1 | 17.6 | 42 |
GSM215282 | HMVEC_atorvastatin_rep3 | 9.3 | 22 |
GSM215344 | HMVEC_atorvastatin_rep2 | 32 | 59 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 14.1 | 27 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 11.1 | 23 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | ||
GSM215294 | HMVEC_SLx2119_rep1 | 24.3 | 60 |
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | ||
GSM215297 | PASMC_vehicle_rep1 | ||
GSM215298 | PASMC_vehicle_rep2 | 1.9 | 3 |
GSM215310 | PASMC_vehicle_rep3 | ||
GSM215311 | PASMC_atorvastatin_rep1 | 13.1 | 23 |
GSM215312 | PASMC_atorvastatin_rep2 | 16.1 | 26 |
GSM215313 | PASMC_atorvastatin_rep3 | 42.4 | 53 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 34.5 | 50 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 13.7 | 27 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | ||
GSM215327 | PASMC_SLx2119_rep1 | ||
GSM215328 | PASMC_SLx2119_rep2 | 8.4 | 16 |
GSM215329 | PASMC_SLx2119_rep3 | 10.2 | 20 |
GSM215330 | Fibroblasts_vehicle_rep1 | 87.5 | 74 |
GSM215331 | Fibroblasts_vehicle_rep2 | 58.7 | 70 |
GSM215332 | Fibroblasts_vehicle_rep3 | 68.5 | 72 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 52.6 | 69 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 86.1 | 73 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 21.4 | 46 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 57.9 | 71 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 46.8 | 69 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 23 | 53 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 44 | 67 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 34 | 63 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 1.6 | 4 |